SeaStar Medical Holding Corporation Common Stock (ICU) Stock Price

ICUStock
$2.90−53.97%52W
Market Cap$15.26M
P/E—
PEG Ratio—
Div yield—
Beta-1.10

ICU Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-32.57%
Price vs S&P 500 (4W)-17.67%
VGM Score53.28

ICU Earnings Surprise History

QuarterReport dateEPS estimateEPS actualSurprise
Q2 2026-$0.97-$0.91+6.19%(+$0.06)
Q1 2026-$0.82-$0.90-9.09%(-$0.08)
Q4 2025-$1.01-$0.80+21.18%(+$0.21)
Q3 2025-$1.50-$1.30+13.33%(+$0.20)
Q2 2025-$4.30-$1.80+58.14%(+$2.50)

ICU Analyst Recommendations

Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.00
4.00
4.00
4.00

Industry Peers — Surgical & Medical Instruments(142)

SymbolValue ScoreGrowth ScoreMomentum ScoreP/S Ratio (TTM)Revenue Growth (5Y)Gross Margin (TTM)Operating Margin (TTM)Price
ICUSeaStar Medical Holding Corporation Common Stock
DAD7.5x—92.6%-816.6%$2.90
SYKStryker CorporationCBC4.4x11.8%65.3%21.3%$294.66
MMM3M CompanyCDB3.4x-5.0%39.4%18.4%$164.75
BSXBoston Scientific Corp.CBC3.1x15.2%69.5%19.8%$44.39
BDXBecton, Dickinson and Co.BDA2.5x6.3%46.7%9.6%$191.75
MDLNMedline Inc. Class A common stockCDC1.6x—26.2%6.0%$35.96
RMDResMed Inc.CCB5.9x12.1%61.1%33.4%$238.97
DXCMDexCom, Inc.CBB6.5x19.3%64.3%22.9%$86.04
WSTWest Pharmaceutical Services, Inc.DCA8.5x7.4%36.8%20.4%$384.02
SOLVSolventum CorporationCCB1.8x—54.8%23.9%$85.81
BAXBaxter International Inc.BDB1.1x-0.8%30.7%-2.3%$25.28

About SeaStar Medical Holding Corporation Common Stock

SeaStar Medical develops extracorporeal therapies designed to reduce hyperinflammation and its damaging effects on vital organs. The company's proprietary platform targets the inflammatory cells and cytokines that drive systemic immune responses and tissue damage. It operates a single Device segment focused on commercializing these therapeutic solutions.